🏛️ Verified NIH Record • Updated 2026-07-22
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease (NCT04809363)
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
🔵 Active, Not Recruiting Phase4 📋 Clinical Research Protocol Sponsor: Takeda
🩺 Plain-English Summary (8th-Grade Level)
CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. The main aim of the study is to explore the use of CDPATH™ to describe a participant's risk profile and to have discussions with their doctor about the potential path of their Crohn's disease. The number of visits will be decided by the study clinic according to their standard practice.
Who can join: Review the eligibility criteria below.
Location: Arizona Arthritis & Rheumatology Research, PLLC — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
- CDPATH™ (OTHER)
- Blood Draw (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (44 Sites)
Showing the first 25 of 44 sites.
- Arizona Arthritis & Rheumatology Research, PLLC — Phoenix, Arizona
- VA Loma Linda Healthcare System — Loma Linda, California
- United Medical Doctors — Murrieta, California
- University of Southern California Medical Center — Newport Beach, California
- Clinnova Research Solutions — Orange, California
- University of California at Irvine Medical Center — Orange, California
- Kaiser Permanate of Colorado — Aurora, Colorado
- Medical Research Center of Connecticut, LLC — Hamden, Connecticut
- West Central Gastroenterology d/b/a Gastro Florida — Clearwater, Florida
- Gastroenterology Associates of Pensacola, PA — Pensacola, Florida
- Grand Teton Research Group, PLL — Idaho Falls, Idaho
- GI Alliance — Arlington Heights, Illinois
- GI Alliance — Gurnee, Illinois
- Comprehensive Gastrointestinal Health — Northbrook, Illinois
- Rockford Gastroenterology Associates, Ltd. — Rockford, Illinois
- Indiana University — Indianapolis, Indiana
- Iowa Digestive Disease Center — Clive, Iowa
- University of Iowa Hospitals & Clinics — Iowa City, Iowa
- University of Kansas Medical Center Research Institute, Inc. — Kansas City, Kansas
- GI Alliance - Baton Rouge — Baton Rouge, Louisiana
- Louisiana Research Center, LLC — Shreveport, Louisiana
- Gastro Center of Maryland — Columbia, Maryland
- Lahey Clinic Inc. - PARENT ACCOUNT — Burlington, Massachusetts
- UMASS Memorial Medical Center — Worcester, Massachusetts
- University of New Mexico — Albuquerque, New Mexico
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Crohn's Disease
- A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) — Birmingham, Alabama
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Birmingham, Alabama
- A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. — Sun City, Arizona
- Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice. — Blacktown, New South Wales
- Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients — San Francisco, California
- Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis — Boston, Massachusetts
Explore by condition: All Crohn's Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.